Märkte
| Wertpapier | Kurs ▼ | % | Buy | Sell | Kursziel | Potential |
|---|---|---|---|---|---|---|
| Sophiris Bio Inc. |
0,20 €
05.08.20 |
- | 0 | 0 | - | - |
| Acura Pharmaceuticals |
0,20 €
27.07.22 |
- | 0 | 0 | - | - |
| Biocept Inc. |
0,20 €
19.08.23 |
4,24 % | 0 | 0 | - | - |
| Qualigen Therapeutics Inc. |
0,19 €
22:26 |
-10,10 % | 0 | 0 | - | - |
| iBio Inc. |
0,18 €
28.11.23 |
-28,52 % | 2 | 2 | 4,59 € | 2408,47 % |
| EyeGate Pharmaceuticals Inc |
0,15 €
30.08.19 |
1,31 % | 0 | 0 | - | - |
| Cytori Therapeutics Inc. |
0,14 €
30.07.19 |
- | 0 | 0 | - | - |
| Histogenics Corp. |
0,14 €
30.09.19 |
-30,94 % | 0 | 0 | - | - |
| Vyant Bio Inc. |
0,13 €
09.01.24 |
- | 0 | 0 | - | - |
| Enzon Pharmaceuticals |
0,12 €
09.07.24 |
-0,83 % | 0 | 0 | - | - |
| Aptevo Therapeutics Inc. |
0,12 €
05.03.24 |
-10,29 % | 0 | 0 | - | - |
| Jaguar Health Inc. |
0,12 €
22.05.24 |
-7,44 % | 0 | 0 | - | - |
| Nuvectra Corp |
0,10 €
13.12.19 |
-23,08 % | 0 | 0 | - | - |
| Aradigm Corp. New |
0,097 €
18.07.19 |
-12,15 % | 0 | 0 | - | - |
| Seelos Therapeutics Inc. |
0,097 €
27.11.23 |
-19,49 % | 1 | 0 | - | - |
| Heat Biologics Inc. |
0,069 €
14.06.24 |
-24,86 % | 0 | 0 | - | - |
| BioLase Inc. |
0,067 €
14.06.23 |
-5,52 % | 0 | 10 | - | - |
| Sintx Technologies Inc. |
0,062 €
06.06.24 |
-16,89 % | 0 | 0 | - | - |
| Melinta Therapeutics Inc. |
0,060 €
21.04.20 |
- | 0 | 0 | - | - |
| Ampio Pharmaceuticals Inc. |
0,060 €
07.01.23 |
- | 0 | 31 | - | - |
| ContraFect Corp. |
0,059 €
08.06.23 |
- | 0 | 0 | - | - |
| Advaxis Inc. |
0,059 €
23.09.22 |
- | 0 | 21 | - | - |
| CytRx Corp. |
0,056 €
17.05.23 |
- | 0 | 0 | - | - |
| Alliqua BioMedical Inc |
0,050 €
27.01.22 |
- | 0 | 0 | - | - |
| INSYS Therapeutics Inc |
0,042 €
19.02.20 |
5,00 % | 0 | 0 | - | - |
| Teligent Inc. |
0,017 €
06.04.22 |
725,00 % | 0 | 0 | - | - |
| Sienna Biopharmaceuticals |
0,010 €
10.03.20 |
- | 0 | 0 | - | - |
| Aac Hldgs Inc. |
0,003 €
14.12.20 |
50,00 % | 0 | 0 | - | - |
| Immune Pharmaceuticals Inc |
0,001 €
27.07.22 |
-75,00 % | 0 | 0 | - | - |
| Aceto Corp. |
-
- |
- | 0 | 0 | - | - |